Schwartz Eric
Known title: EVP, Chief Legal Officer & SecCIK: 0001329100
Associated companies
Transaction History
| IART | ▼ Sell | Tax Withholding | 1,538 | $37K | 3/11/2025 | View on chart |
| IART | ▼ Sell | Tax Withholding | 1,180 | $28K | 3/11/2025 | View on chart |
| IART | ▼ Sell | Tax Withholding | 773 | $17K | 3/10/2025 | View on chart |
| IART | ▼ Sell | Open Market | 4,070 | $100K | 12/3/2024 | View on chart |
| IART | ▼ Sell | Tax Withholding | 1,090 | $39K | 3/12/2024 | View on chart |
| IART | ▼ Sell | Tax Withholding | 348 | $12K | 3/12/2024 | View on chart |
| IART | ▼ Sell | Tax Withholding | 1,371 | $50K | 3/11/2024 | View on chart |
| IART | ▲ Buy | Grant | 7,745 | $0 | 3/11/2024 | View on chart |
| IART | ▲ Buy | Grant | 8,283 | $0 | 3/11/2024 | View on chart |
| IART | ▼ Sell | Tax Withholding | 799 | $29K | 3/10/2024 | View on chart |
| IART | ▲ Buy | Grant | 2,564 | $0 | 2/20/2024 | View on chart |
| IART | ▲ Buy | Open Market | 2,640 | $100K | 6/1/2023 | View on chart |
| IART | ▼ Sell | Tax Withholding | 915 | $48K | 3/13/2023 | View on chart |
| IART | ▼ Sell | Tax Withholding | 416 | $26K | 3/13/2023 | View on chart |
| IART | ▼ Sell | Tax Withholding | 594 | $31K | 3/12/2023 | View on chart |
| IART | ▼ Sell | Tax Withholding | 238 | $13K | 3/12/2023 | View on chart |
| IART | ▼ Sell | Tax Withholding | 338 | $18K | 3/12/2023 | View on chart |
| IART | ▼ Sell | Tax Withholding | 2,393 | $127K | 3/11/2023 | View on chart |
| IART | ▼ Sell | Tax Withholding | 1,371 | $72K | 3/11/2023 | View on chart |
| IART | ▲ Buy | Grant | 5,070 | $0 | 3/10/2023 | View on chart |
| IART | ▲ Buy | Grant | 2,156 | $0 | 2/13/2023 | View on chart |
| IART | ▲ Buy | Grant | 560 | $0 | 2/13/2023 | View on chart |
| IART | ▲ Buy | Grant | 1,400 | $0 | 2/13/2023 | View on chart |
| IART | ▲ Buy | Grant | 5,641 | $0 | 2/13/2023 | View on chart |
| IART | ▼ Sell | Tax Withholding | 404 | $26K | 3/13/2022 | View on chart |
| IART | ▼ Sell | Tax Withholding | 286 | $19K | 3/13/2022 | View on chart |
| IART | ▼ Sell | Tax Withholding | 691 | $45K | 3/13/2022 | View on chart |
| IART | ▼ Sell | Tax Withholding | 1,488 | $97K | 3/13/2022 | View on chart |
| IART | ▼ Sell | Tax Withholding | 218 | $14K | 3/12/2022 | View on chart |
| IART | ▼ Sell | Tax Withholding | 873 | $57K | 3/12/2022 | View on chart |
| IART | ▼ Sell | Tax Withholding | 349 | $23K | 3/12/2022 | View on chart |
| IART | ▲ Buy | Grant | 9,792 | $0 | 3/11/2022 | View on chart |
| IART | ▼ Sell | Tax Withholding | 1,712 | $114K | 3/1/2022 | View on chart |
| IART | ▲ Buy | Grant | 2,520 | $0 | 2/11/2022 | View on chart |
| IART | ▲ Buy | Grant | 3,565 | $0 | 2/11/2022 | View on chart |
| IART | ▲ Buy | Grant | 4,454 | $0 | 2/11/2022 | View on chart |
| IART | ▼ Sell | Tax Withholding | 2,414 | $151K | 12/3/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 25, 2026
IART May Be 48% Undervalued Based on Cash Flow Analysis
A recent Yahoo analysis suggests Integra LifeSciences shares could be trading about 48% below their intrinsic value when cash flow is considered. The stock sits near its 13‑touch support level of $9.10 and an RSI of 41.6, indicating neither overbought nor oversold conditions. The average analyst target is $19.56, well above the current price, highlighting a potential valuation gap. This analysis may prompt a closer look at the company’s cash flow performance relative to market expectations.
IART May Be 48% Undervalued Based on Cash Flow Analysis. A recent Yahoo analysis suggests Integra LifeSciences shares could be trading about 48% below their intrinsic value when cash flow is considered. The stock sits near its 13‑touch support level of $9.10 and an RSI of 41.6, indicating neither overbought nor oversold conditions. The average analyst target is $19.56, well above the current price, highlighting a potential valuation gap. This analysis may prompt a closer look at the company’s cash flow performance relative to market expectations.